US 9529005
Modulating bacterial MAM polypeptides in pathogenic disease
granted A61KA61K35/74A61K35/741
Quick answer
US patent 9529005 (Modulating bacterial MAM polypeptides in pathogenic disease) held by The Board of Regents of the University of Texas System expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K35/74, A61K35/741, A61K38/164, A61P